Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
280 participants
INTERVENTIONAL
2021-06-06
2021-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
The control group does not receive educational materials about the TissueCypher diagnostic test and will treat their simulated patients with the current standard of care tools.
No interventions assigned to this group
Intervention Group 1
Intervention group 1 receives educational materials about the TissueCypher diagnostic test. These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report. This intervention group is then forced to use the test results in treating their simulated patients.
Educational materials for TissueCypher
These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report.
Intervention Group 2
Intervention group 2 receives educational materials about the TissueCypher diagnostic test. These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report. This intervention group then gets to decide whether or not they want to use the TissueCypher test results for their simulated patients.
Educational materials for TissueCypher
These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational materials for TissueCypher
These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Averages at least 20 hours per week of clinical and patient care duties over the last six months
* performs either diagnostic endoscopy, interventional endoscopy, upper GI surgery, or bariatric surgery
* practicing in the US
* english speaking
* access to the internet
* informed and voluntarily consented to be in the study
Exclusion Criteria
* unable to access the internet
* not practicing in the US
* not averaging at least 20 hours per week of clinical or patient care duties over the last six months
* does not perform either diagnostic endoscopy, interventional endoscopy, upper GI surgery, or bariatric surgery
* does not voluntarily consent to be in the study
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qure Healthcare, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
QURE Healthcare
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Peabody JW, Cruz JDC, Ganesan D, Paculdo D, Critchley-Thorne RJ, Wani S, Shaheen NJ. A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB. Clin Transl Gastroenterol. 2024 Jan 1;15(1):e00644. doi: 10.14309/ctg.0000000000000644.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00056136
Identifier Type: -
Identifier Source: org_study_id